Sana Biotechnology (SANA) – Market Performance Update
Sana Biotechnology (NASDAQ: SANA) closed at USD 2.35 on Thursday, 22 November 2026, down 0.42 % from the previous trading session. The closing price was recorded at 07:21 AM Central Europe time.
Key Trading Metrics (24‑Hour Period)
| Metric | Value |
|---|---|
| Current share price | USD 2.35 |
| Trading volume | USD 5.6 million |
| Shares outstanding | 299.4 million |
| Market capitalization | USD 706.5 million |
| 200‑day simple moving average | USD 3.47 |
| 52‑week high | USD 5.90 (24 Oct 2025) |
| 52‑week low | USD 2.22 (19 Oct 2026) |
The company’s shares have declined 29.43 % since the close of the previous month.
Comparative Performance of Related Stocks (Last 24 Hours)
- Navient (NAVI): up 0.56 % to USD 9.03; market cap USD 842.2 million.
- Corvus (CRVS): down 1.76 % to USD 10.05; market cap USD 845.4 million.
- Suncoke Energy (SXC): up 0.82 % to USD 9.89; market cap USD 832.6 million.
- Standard Motor Prods (SMP): down 0.11 % to USD 37.07; market cap USD 829.1 million; price‑to‑earnings ratio 9.42.
- Esperion Therapeutics (0ET.F): down 0.31 % to USD 3.18; market cap USD 819.5 million.
Company Overview
Sana Biotechnology, Inc. is headquartered in Seattle, Washington and operates within the Health Care sector. The company specializes in the development and delivery of engineered cells for therapeutic use, aiming to replace damaged cells and tissues in patients with various diseases. Sana Biotechnology is listed on the Nasdaq stock exchange. More information can be found on the company’s website at www.sana.com .
